ADZENYS ER (AMPHETAMINE) — FDA Approval NDA204325 (NEOS THERAPS INC)
ADZENYS ER (AMPHETAMINE) — FDA Approval NDA204325 (NEOS THERAPS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ADZENYS ER; Active ingredients: AMPHETAMINE; Application number: NDA204325.
| Brand name | ADZENYS ER |
|---|---|
| Active ingredients | AMPHETAMINE |
| Application number | NDA204325 |
| Sponsor | NEOS THERAPS INC |
| Dosage form | SUSPENSION, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20170915 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →